Berkshire Hathaway Sells $69M of DaVita Stock Amid HHS Kidney Reforms, Securities Fraud Probe

What Does DaVita (DVA) Stock Risk From The HHS Reform Probe?

An interim U.S. policy covers six peptides, none FDA-approved

HHS Draft Policy Eases Enforcement on 6 Compounded Peptides

Top U.S. Health Official Backed a Medication Policy Shift That Benefited a Company She Has Stock In

HIMS Stock Jumps 5% After HHS Temporarily Clears Compounding Of Six Peptides

Hims & Hers Health (HIMS) Stock Rises on HHS Interim Policy Allo

HHS launches vaccine injury effort; Queens pharmacy owner charged in HIV drug scheme; AI chatbots unreliable on home BP monitors — Morning Medical Update

Exclusive: HHS launches project to speed up clinical trials

What's behind HHS claims that gender-affirming care 'may' radicalize

Harte Hanks Announces Expiration of "Go-Shop Period" and Designation of "Exempted Parties"

HHS plans new FDA deputy commissioner roles for technology and drugs, sources say

Star Equity Holdings Enters Into Merger Agreement to Acquire Harte Hanks

Harte Hanks Enters Definitive Agreement to Be Acquired by Star Equity Holdings for $5.00 Per Share

HHS moves to tighten oversight of food ingredients as safety concerns mount